Weil Company, Inc. Abb Vie Inc. Transaction History

Weil Company, Inc.

$239 Million
Q1 2024

A detailed history of Weil Company, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Weil Company, Inc. holds 4,020 shares of ABBV stock, worth $658,636. This represents 0.31% of its overall portfolio holdings.

Number of Shares

4,020

Previous 5,690 29.35%

Holding current value

$658,636

Previous $881,000 16.91%

% of portfolio

0.31%

Previous 0.4%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$159.82 - $182.1 $266,899 - $304,107	-1,670 Reduced 29.35%	4,020 $732,000
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $5,504 - $6,998	40 Added 0.71%	5,690 $871,000
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $21,908 - $27,182	-166 Reduced 2.85%	5,650 $916,000
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $13,213 - $16,719	123 Added 2.16%	5,816 $787,000
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $17,570 - $19,574	-167 Reduced 2.85%	5,693 $641,000

Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $220 - $294	-3 Reduced 0.05%	5,860 $575,000
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $19,350 - $29,337	-300 Reduced 4.87%	5,863 $447,000
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $15,147 - $18,952	-210 Reduced 3.3%	6,163 $546,000
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $157,450 - $189,300	-2,500 Reduced 28.18%	6,373 $482,000
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $3,942 - $5,038	60 Added 0.68%	8,873 $645,000
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $6,617 - $8,160	-85 Reduced 0.96%	8,813 $812,000
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $4,000 - $4,447	-45 Reduced 0.5%	8,898 $842,000
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $12,120 - $14,341	135 Added 1.53%	8,943 $829,000
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $230,025 - $308,025	2,500 Added 39.63%	8,808 $834,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $564,944 - $619,508	6,308	6,308 $610,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $290B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weil Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Weil Company, Inc. with notifications on news.

Account